House committee to press FDA Commissioner Robert Califf on shortage oversight, other issues

Amid ongoing drug shortages and other headline-grabbing issues that fall under the FDA’s purview, the House Committee on Oversight and Accountability is putting the agency’s commissioner Robert Califf, M.D., on the hot seat.